Resultados da busca - Amir Baghbanzadeh
- Mostrando 1 - 10 resultados de 10
-
1
-
2
Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment por Darya Javadrashid, Amir Baghbanzadeh, Afshin Derakhshani, Patrizia Leone, Nicola Silvestris, Vito Racanelli, Antonio Giovanni Solimando, Behzad Baradaran
Publicado em 2021Revisão -
3
MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers por Omid Kooshkaki, Zohre Rezaei, Meysam Rahmati, Parviz Vahedi, Afshin Derakhshani, Oronzo Brunetti, Amir Baghbanzadeh, Behzad Mansoori, Nicola Silvestris, Behzad Baradaran
Publicado em 2020Revisão -
4
The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment por Nadia Bolandi, Afshin Derakhshani, Nima Hemmat, Amir Baghbanzadeh, Zahra Asadzadeh, Mina Afrashteh Nour, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris, Behzad Baradaran
Publicado em 2021Revisão -
5
Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects por Shima Makaremi, Zahra Asadzadeh, Nima Hemmat, Amir Baghbanzadeh, Alessandro Sgambato, Farid Ghorbaninezhad, Hossein Safarpour, Antonella Argentiero, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris, Behzad Baradaran
Publicado em 2021Revisão -
6
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies? por Negar Hosseinkhani, Afshin Derakhshani, Omid Kooshkaki, Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Amir Baghbanzadeh, Hossein Safarpour, Ahad Mokhtarzadeh, Oronzo Brunetti, Simon Yue, Nicola Silvestris, Behzad Baradaran
Publicado em 2020Revisão -
7
Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systema... por Parisa Lotfinejad, Mohammad Asghari Jafarabadi, Mahdi Abdoli Shadbad, Tohid Kazemi, Fariba Pashazadeh, Siamak Sandoghchian Shotorbani, Farhad Jadidi‐Niaragh, Amir Baghbanzadeh, Nafiseh Vahed, Nicola Silvestris, Behzad Baradaran
Publicado em 2020Revisão -
8
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer por Hajar Alemohammad, Basira Najafzadeh, Zahra Asadzadeh, Amir Baghbanzadeh, Farid Ghorbaninezhad, Arezoo Najafzadeh, Hossein Safarpour, Renato Bernardini, Oronzo Brunetti, Margherita Sonnessa, Rossella Fasano, Nicola Silvestris, Behzad Baradaran
Publicado em 2021Revisão -
9
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV por Nima Hemmat, Zahra Asadzadeh, Noora Karim Ahangar, Hajar Alemohammad, Basira Najafzadeh, Afshin Derakhshani, Amir Baghbanzadeh, Hossein Bannazadeh Baghi, Darya Javadrashid, Souzan Najafi, Meriadeg Ar Gouilh, Behzad Baradaran
Publicado em 2021Revisão -
10
Thrombolytic Agents: Nanocarriers in Controlled Release por Soodabeh Hassanpour, Han‐Jun Kim, Arezoo Saadati, Peyton Tebon, Chengbin Xue, Floor W. van den Dolder, Jai Thakor, Behzad Baradaran, Jafar Mosafer, Amir Baghbanzadeh, Natan Roberto de Barros, Mahmoud Hashemzaei, KangJu Lee, Junmin Lee, Shiming Zhang, Wujin Sun, Hyun‐Jong Cho, Samad Ahadian, Nureddin Ashammakhi, Mehmet R. Dokmeci, Ahad Mokhtarzadeh, Ali Khademhosseini
Publicado em 2020Revisão
Ferramentas de busca:
Assuntos relacionados
Medicine
Biology
Cancer
Internal medicine
Cancer research
Immunology
Immune system
Immunotherapy
Cancer immunotherapy
Immune checkpoint
Tumor microenvironment
Biochemistry
T cell
Cancer cell
Genetics
In vitro
Oncology
Receptor
Suppressor
2019-20 coronavirus outbreak
Angiogenesis
Antigen
Betacoronavirus
Bioinformatics
Blockade
Breast cancer
CD40
CD80
CD86
CTLA-4